Leadership Team

Jaswinder Khera

Managing Director US

At WEP Clinical, Jaswinder oversees the growth and strategy of the business in the Americas. Jaswinder brings over 30 years of experience in the pharmaceutical Industry in senior sales and marketing positions with Sanofi, MSD and Astra. He also held senior management positions in operations and business development during his 10 years with Quintiles.

Jaswant Khera

Managing Director EU

Following sales and management experience with Pfizer, where he led a team that marketed the global blockbusters Lipitor & Neurontin, Jaswant went on to launch WE Pharma, now called WEP Clinical. He brings with him 25 years of commercial, strategic, operational and marketing experience as well as a deep understanding of international markets and commercialization of drugs. Currently serving as Managing Director EU, he is responsible for the growth and strategy of the business.

Bob Goodman

Chief Commercial Officer

Bob has been a life sciences commercial leader for over 30-years with a wide range of experience that foundationally started at Pfizer as a 5-time Presidents Club sales and sales leadership winner. This was followed with leadership roles at Thermo Fisher, leading the BioServices Division, Cardiocore’s Cardiac Monitoring Services business as well as BioTelemetry’s Clinical Research Imaging and Cardiac Safety business. Most recently, Bob was the leader of the Philips Population Health business with full P&L responsibility and just prior to joining WEP was also Chief Commercial Officer at Actigraph.

SHAHEEN LIMBADA | CHIEF OPERATING OFFICER

Shaheen limbada

Chief Operating Officer

Shaheen is a seasoned executive in the CRO and pharmaceutical industry, with over 23 years of experience in drug development, clinical operations, innovation and strategy, pharmacovigilance and post trial access solutions.   He has worked in large pharma and CROs settings including AstraZeneca, LEO Pharma, Veristat and Topstone Research. Shaheen is a visionary leader who combines scientific expertise, business acumen, and operational excellence to deliver outstanding results for WEP clients and stakeholders. He is passionate about advancing clinical research and improving patient outcomes through innovation, collaboration and patient access.

Karl Challender

Chief Financial Officer

Karl has over 25 years of experience in the pharmaceutical and clinical research industry and has previously worked with organisations including Worldwide Clinical Trials, Novartis and Alcon. Karl brings a wealth of functional experience covering Operations, Finance, Logistics, Project Management and Sales and has a passion for patient service and delivery excellence.

LEE SUTTON

VP, Business Development (EAPs)

Lee has been in the pharmaceutical & logistics industry for over 10 years. He joined WEP Clinical in 2020, after spending 7 years with Thermo Fisher Scientific where he led global commercial operations within a supply chain business unit. In his current role, Lee is responsible for driving the strategy & growth of WEP’s Expanded Access and Post-Approval Named Patient Programs. Lee is a highly experienced, results-oriented global business development leader who possesses strong strategic capabilities and knowledge of managing clinical and commercial supply chains. His innovative thinking and straightforward business approach drives value and exceptional service to our clients and their patients.

Simon Clayton

VP, Strategic Alliances

At WEP Clinical, Simon is responsible for expanding our commercial portfolio and growing our partnerships with Biopharmaceutical companies. Simon has 20 years of international experience in the Pharmaceutical industry with senior roles in Marketing, Business Management and Business Development at AstraZeneca, Abbvie and Clinigen.

Heather Masters

VP Global Market Access

Heather is responsible for Market Access at WEP Clinical, working with our partners to secure optimal pricing, access and reimbursement of licenced portfolios. Heather has been a successful business leader in the Pharmaceutical industry for nearly 20 years, and has extensive knowledge of global healthcare systems and expertise in developing Market Access strategies for innovative therapies in Oncology and Rare Diseases. Heather has held a number of senior management roles in Commercial Marketing & Market Access for Novartis AG and has worked as a Business Consultant with various biopharmaceutical companies across a wide range of therapy areas.

WYndi Phillips

VP, Project Management

Wyndi is responsible for overseeing and leading the WEP Clinical global Project Management team, ensuring strong customer service and timely delivery of medications to patients around the world through Expanded Access and Post-Approval Named Patient Programs. Previously, she successfully led global teams in the management of clinical drug supply as Executive Director of Clinical Supplies at PRA Health Sciences and as a Project Group Manager at Almac Clinical Services. Wyndi earned her Doctor of Pharmacy degree from Campbell University and completed a residency at Mercer University. She has worked as a clinical pharmacist in hospital, ambulatory care, and community settings.

Kevin Weatherwax

VP, Regulatory Affairs

As VP and Head of Regulatory Affairs, Kevin is responsible for understanding, developing, and managing the Regulatory Affairs strategy for WEP's Expanded Access Programs, Compassionate Use Programs, and Post-Approval Named Patient Programs. Kevin has over 25 years of experience in the pre-approval/expanded access and clinical research space. In his previous role as the Managing Director of the Michigan Institute for Clinical & Health Research (MICHR) and Adjunct Associate Clinical Professor in the College of Pharmacy at the University of Michigan, Kevin was instrumental in the development of institutional policy and processes as they relate to FDA-regulated research.

MATT COMSTOCK

VP, Data and Safety Services

Matt has over two decades of experience working in the pharmaceutical and CRO space. He worked previously in data management and finance at Quintiles for nearly 15 years and also has experience in research, strategic account management, sales and relationship development.  As the VP of Data and Safety Services at WEP Clinical, Matt is responsible for overseeing Data Management, Pharmacovigilance and Registry trial activities in alignment with the overall WEP business strategy.

Prashant Desai

Head of Medical Affairs

A physician by training, Prashant has a 23 year career in clinical research which includes operations, project management, site management, business development and medical affairs. These roles were at CROs including Quintiles, Parexel, Premier Research and Ergomed, where he initially focussed on cardiovascular safety and then expanded to start up and set up activities for global clinical trials in a variety of indications and therapy areas. Prashant has also worked with end point data collection at organisations such as Clario (previously ERT) and Calyx. A passionate team player, Prashant’s focus remains patient care and at WEP leads the Medical Affairs function.

antony reynolds

VP, Head of Wren Healthcare

Antony is a seasoned professional with over 20 years of experience in the biotechnology and pharmaceutical industry. He has held a variety of sales and management roles and, in 2018, he founded Wren Healthcare, a specialist nursing and clinical education company. At Wren Healthcare, Antony leads the company's global services, leveraging his deep knowledge of Decentralized Clinical Trial (DCT) market. Under Antony's leadership, Wren Healthcare has become a leading provider of DCT services, supporting clients across all study phases and a broad spectrum of therapeutic areas.